OncoSec Medical Incorporated (ONCS)
US68234L4059 - Common Stock
| TTM (2023-1-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | 2020 (2020-7-31) | 2019 (2019-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -29.39M | -34.18M | -45.17M | -42.25M | -30.28M | |||
| Depreciation Amortization | 252.17K | 257.29K | 236.86K | 220.00K | 240.00K | |||
| Change In Working Capital | 2.05M | -1.23M | -2.49M | 3.77M | -3.55M | |||
| Interest Paid | 26.02K | 20.93K | 10.30K | 0.00 | 0.00 | |||
| Taxes Paid | 2.97K | 2.97K | 4.99K | 0.00 | 0.00 | |||
| Other non cash items | 2.09M | 3.01M | 5.63M | 5.12M | 4.58M | |||
| OPERATING CASH FLOW | -24.99M | -32.14M | -41.79M | -33.15M | -29.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -244.86K | -799.60K | N/A | -10.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 23.21M | |||
| INVESTING CASH FLOW | N/A | -244.86K | -799.60K | N/A | 23.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 854.33K | -1.33M | -619.11K | 810.00K | -80.00K | |||
| Stock Issued/Repurchased | N/A | 204.90K | 68.28M | 29.80M | 28.49M | |||
| Other Financing Activity | -812.14K | -40.96K | 547.07K | -2.22M | -1.21M | |||
| FINANCING CASH FLOW | 3.54M | -1.16M | 68.21M | 28.40M | 27.20M | |||
| Exchange Rate Effect | -84.88K | -106.67K | -18.62K | -50.00K | -50.00K | |||
| CHANGE IN CASH | -21.55M | -33.65M | 25.60M | -4.79M | 21.35M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -24.99M | -32.14M | -41.79M | -33.15M | -29.00M | |||
| Capital Expenditure | N/A | -244.86K | -799.60K | N/A | -10.00K | |||
| FREE CASH FLOW | -25.01M | -32.38M | -42.59M | -33.15M | -29.01M | |||
All data in USD